Thrombospondin-1 is a major activator of TGF-β in fibrotic renal disease in the rat in vivo

Daniel C, Wiede J, Krutzsch HC, Ribeiro SMF, Roberts DD, Murphy-Ullrich JE, Hugo C (2004)

Publication Language: English

Publication Type: Journal article

Publication year: 2004

Journal

Kidney International Nature Publishing Group: Open Access Hybrid Model Option A

Book Volume: 65

Pages Range: 459-468

Journal Issue: 2

DOI: 10.1111/j.1523-1755.2004.00395.x

Abstract

Background. Transforming growth factor-β (TGF-β), a profibrotic cytokine involved in many scarring processes, has to be activated extracellularly before it can bind to its receptors. Thrombospondin 1 (TSP1), a multifunctional matricellular glycoprotein, has been identified as an activator of TGF-β in in vitro systems and during mouse postnatal development in vivo. TSP1 is expressed de novo in many inflammatory disease processes, including glomerular disease. Methods. In this study we investigated whether peptides specifically interfering with the activation process of TGF-β by TSP1 may be able to block activation of TGF-β in an in vivo model of mesangial proliferative glomerulonephritis. Results. Continuous intravenous infusion of blocking peptide by minipumps significantly reduced expression of active TGF-β in glomeruli on day 7 of disease as indicated by immunohistochemistry, bioassay, and activation of the TGF-β signal transduction pathway, while total TGF-β expression was unchanged. Inhibition of glomerular TGF-β activation was accompanied by a decrease of glomerular extracellular matrix accumulation and proteinuria, but was without effect on mesangial cell proliferation or influx of monocytes/macrophages. Conclusion. TSP1 is a major endogenous activator of TGF-β in experimental inflammatory glomerular disease. Drugs interfering with the activation of TGF-β by locally produced TSP1 may be considered as a future specific treatment of scarring kidney disease.

Authors with CRIS profile

Christoph Daniel Department of Nephropathology

Involved external institutions

University of Alabama at Birmingham (UAB) US United States (USA) (US) US National Institutes of Health (NIH) US United States (USA) (US)

How to cite

APA:

Daniel, C., Wiede, J., Krutzsch, H.C., Ribeiro, S.M.F., Roberts, D.D., Murphy-Ullrich, J.E., & Hugo, C. (2004). Thrombospondin-1 is a major activator of TGF-β in fibrotic renal disease in the rat in vivo. Kidney International, 65(2), 459-468. https://doi.org/10.1111/j.1523-1755.2004.00395.x

MLA:

Daniel, Christoph, et al. "Thrombospondin-1 is a major activator of TGF-β in fibrotic renal disease in the rat in vivo." Kidney International 65.2 (2004): 459-468.

BibTeX: Download